InVivoMAb anti-mouse/human CD44
BE0039
ApplicationsNeutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse/human CD44
- Delivery Days Customer7
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDIM7
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostRat
- IsotypeIgG2b
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Lee SW, Ryu JH, Do MJ, et al. NiCHE Platform: Nature-Inspired Catechol-Conjugated Hyaluronic Acid Environment Platform for Salivary Gland Tissue Engineering. ACS Appl Mater Interfaces. 2020,12(4):4285-4294. doi: 10.1021/acsami.9b20546Read this paper
- Liu S, Cheng C. Akt Signaling Is Sustained by a CD44 Splice Isoform-Mediated Positive Feedback Loop. Cancer Res. 2017,77(14):3791-3801. doi: 10.1158/0008-5472.CAN-16-2545Read this paper
- Guidotti LG, Inverso D, Sironi L, et al. Immunosurveillance of the liver by intravascular effector CD8(+) T cells. Cell. 2015,161(3):486-500. doi: 10.1016/j.cell.2015.03.005Read this paper
- Mott PJ, Lazarus AH. CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis. PLoS One. 2013,8(6):e65805. doi: 10.1371/journal.pone.0065805Read this paper
- Hutás G, Bajnok E, Gál I, et al. CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis. Blood. 2008,112(13):4999-5006. doi: 10.1182/blood-2008-04-150383Read this paper
